Table 2.
T0 (baseline) | T1 (1st month) | T2 (2nd month) | T3 (3rd month) | |
---|---|---|---|---|
IOP (mmHg) | 16.06 ± 2.05 (15.40, 16.70) | 15.92 ± 1.32 (15.50, 16.34) | 14.31 ± 1.12 (13.95, 14.65)§ | 14.04 ± 1.17 (13.67, 14.41)§ |
SBP (mmHg) | 126 ± 8.73 (123.24, 128.76) | 127 ± 8.44 (124.33, 129.67) | 125 ± 8.32 (122.37, 127.63) | 128 ± 9.54 (124.98, 131.02) |
DBP (mmHg) | 74 ± 7.85 (71.52, 76.48) | 76 ± 7.72 (73.56, 78.44) | 73 ± 8.13 (70.43, 75.57) | 75 ± 7.97 (72.48, 77.52) |
OPP (mmHg) | 40.82 ± 6.24 (38.85, 42.79) | 40.07 ± 5.54 (38.31, 41.83) | 45.91 ± 7.28 (43.61, 48.21)* | 47.73 ± 6.26 (45.75, 49.71)§ |
HR (beats/min) | 65 ± 2.21 (64.30, 65.70) | 66 ± 2.01 (65.36, 66.64) | 66 ± 1.82 (65.42, 66.58) | 64 ± 1.75 (63.45, 64.55) |
RBF (AU) | 205.3 ± 80.02 (179.99, 230.61) | 197.4 ± 71.23 (174.88, 219.92) | 240.3 ± 65.26 (219.66, 260.94)† | 232.5 ± 86.42 (205.17, 259.83)† |
TRPBF (AU) | 271.3 ± 46.8 (256.50, 286.10) | 275.9 ± 38.4 (263.75, 288.05) | 312.1 ± 54.6 (294.83, 329.37)† | 309.4 ± 41.8 (296.18, 322.62)† |
NRPBF (AU) | 292.4 ± 34.2 (281.59, 303.21) | 302.6 ± 53.7 (285.61, 319.59) | 360.1 ± 43.3 (346.41, 373.79)‡ | 353.8 ± 40.9 (340.87, 366.73)‡ |
MD (dB) | −3.3 ± 1.91 (−3.90, −2.70) | −3.0 ± 1.65 (−3.53, −2.49) | −2.9 ± 1.72 (−3.44, −2.36) | −3.1 ± 1.51 (−3.58, −2.62) |
CPSD (dB) | 5.01 ± 3.42 (3.93, 6.09) | 5.12 ± 3.98 (3.86, 6.38) | 4.5 ± 2.68 (3.65, 5.35) | 4.2 ± 3.12 (3.21, 5.19) |
IOP, Intraocular pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; OPP, ocular perfusion pressure; HR, heart rate; RBF, rim blood flow; TRPBF, temporal retinal peripapillary blood flow; NRPBF, nasal retinal peripapillary blood flow; AU, arbitrary units; MD, mean deviation; CPSD, correct pattern standard deviation; dB = decibel. One-way analysis of variance (anova) was used for statistical analysis; the comparison was performed vs. baseline:
P < 0.02;
p < 0.03;
p < 0.04;
p < 0.05.